We investigated the incidence trends for adenocarcinoma (AC) of the cervix among individuals belonging to the 20-44-year age group in the USA and compared the observed birth cohort incidence patterns with the changing patterns of exposure to potential risk factors associated with AC of the cervix, such as infection with human papillomavirus, use of diethylstilbestrol (DES), obesity, and use of oral contraceptives. Using data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program for 1973-2010, we conducted age-period-cohort modeling to evaluate birth cohort patterns on incidence trends of AC of the cervix over time. The increase in the incidence of AC of the cervix started among those born around the mid 1940s and accelerated up until around the mid 1960s birth cohort in both whites and all races combined, regardless of the assumed period slope. There was a suggestion that the incidence rates of AC of the cervix slowed down after the 1975 birth cohort in both whites and all races combined. DES was used by millions of women in the USA as a synthetic estrogen between the years 1940 and 1971. This time period of DES use among pregnant women parallels the observed birth cohort trends in our study, whereby a notable acceleration in the incidence rates of AC of the cervix was observed among those born in the mid 1940s through the mid 1975s. Thus, our results appear to suggest that in-utero exposure to DES might be at least partly responsible for the observed incidence pattern of AC of the cervix as observed in this study.
Introduction
The overall cervical cancer incidence and mortality rates in the USA have decreased markedly since Pap smear screening was introduced in the 1950s (Waxman, 2005) . However, the two main histologic types of cervical cancer, squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the cervix, have different incidence patterns. Whereas the incidence of SCC has been decreasing, the incidence of AC of the cervix has been increasing in the past several decades (Mathew and George, 2009) , and the increase in the incidence of AC has been more pronounced among younger women (Zheng et al., 1996; Liu et al., 2001; Visioli et al., 2004; Wang et al., 2004) . We have previously demonstrated a strong birth cohort effect to be largely responsible for the observed increasing incidence trends of AC of the cervix among women in the USA between 1973 and 1990 (Zheng et al., 1996 . The increase in the incidence of this subtype was particularly apparent among whites, reaching 4.2% per year among those born in or after 1935 (Zheng et al., 1996) . Thereafter, several studies have explored the incidence trends of AC of the cervix using the US Surveillance, Epidemiology, and End Results (SEER) population data, and have similarly suggested an increase in the incidence of AC of the cervix over the last few decades (Wang et al., 2004; Adegoke et al., 2012; Simard et al., 2012) . However, none of these studies conducted a birth cohort analysis, whereas one study compared the incidence rates of SCC and AC between 1976 and 2005 in the USA using comparative age-period-cohort (APC) modeling (Reimers et al., 2009) .
To understand the current trends and the potential birth cohort pattern of AC of the cervix in the USA, particularly among the age group between 20 and 44 years, which showed an increasing incidence pattern in the latest studies (Liu et al., 2001; Visioli et al., 2004; Wang et al., 2004) , we conducted a birth cohort analysis and used standard APC modeling methods to explore whether a birth cohort effect may continue to explain the incidence of invasive AC of the cervix in the USA from 1973 to 2010. We further compared the observed birth cohort pattern of AC of the cervix with the changing patterns of exposure to potential risk factors associated with this subtype, such as infection with human papillomavirus (HPV; Bosch et al., 2002) , use of diethylstilbestrol The current study was based on data from the SEER program, which was released in April 2013 [SEER*Stat Database: Incidence -SEER 9 Regs Research Data, Nov 2012 Sub (1973 -2010 , Single Ages to 85 + , Katrina/Rita Population Adjustment]. The SEER 9 includes data from ∼ 12% of the US population. On the basis of the International Classification of Disease for Oncology, 3rd edn (ICD-O-3), cervical cancer cases were classified into three histologic subtypes: SCC (ICD-O-3 8050-8130), AC (8160) (8161) (8162) (8570) (8571) (8572) (8573) (8940) (8941) , and adenosquamous (ICD-O-3 8560-8570).
A total of 44 021 newly diagnosed cervical cancer cases were reported to the nine registries of SEER from 1973 to 2010. Among them, 17 831 cases (∼41%) belonged to the 20-44-year age group. For 15 929 patients, excluding 173 patients with unknown race, histologic subtype data were available for analysis. Among them, 12 420 (78%) were of white race and 2848 (18%) had AC. The AC type accounted for ∼ 9% of invasive cervical cancers among whites in 1973, whereas it accounted for 33% of cervical cancer in 2010.
Data analysis
Overall age-adjusted incidence rates for whites and all races combined, as well as sex-specific age-adjusted incidence rates, were calculated using SEER*Stat (8.0.4) from 1973 through 2010 for the 20-44-year age group, with rates adjusted to the 2000 US standard population. The joinpoint analysis was carried out using joinpoint version 4.0.4 (National Cancer Institute, Statistical Research and Applications Branch, Bethesda, MD, USA) by weighted least squares regression of the natural logarithms of the ageadjusted incidence rates. The data were also presented by calendar year and by cohort year of birth to explore the secular trends and the potential birth cohort patterns. The APC analysis based on a log-linear Poisson regression model was carried out for the 20-44-year age group. Age, period, and cohort models were based on five 5-year age intervals between 20 and 44 years, and eight time period intervals (1973-1974, 1975-1979, 1980-1984, 1985-1989, 1990-1994, 1995-2000, 2000-2004, 2005-2010) . Because of the nonidentifiability problem (cohort = year − age), the independent effects of age, period, and cohort cannot be evaluated (Holford, 2003) . However, the cohort effect can be evaluated by constraining the period effect to different assumptions (parameter values β p = 0, − 0.01, or 0.01), where β p = 0 represents a slope of zero, β p = − 0.01 indicates that the period slope was decreasing, and β p = 0.01 indicates that the period slope was increasing during the study period. All models were fit using SAS (version 9.3; SAS Institute Inc., Cary, North Carolina, USA). We only present the data for whites and for all the races combined as the sample size is not large enough to carry out data analysis separately for nonwhites. The significance level was set at 0.05 for a two-sided test.
Results
A total of 2848 cases of AC of the cervix among individuals of a known race between the ages of 20 and 44 years were newly diagnosed from 1973 to 2010. Among these patients, 2420 (84.0%) were white.
The age-adjusted incidence rates of cervical cancer for the 20-44-year age group are presented in Fig. 1 . For white patients, the age-adjusted incidence rates of AC of the cervix for the 20-44-year age group was 1.3/100 000 in 1973, which increased to 2.7/100 000 in 2010. The joinpoint analysis showed an annual percent change of 2.2% (95% confidence interval: 1.8-2.7%) for whites between 1973 and 2010. The incidence trend for all races combined was similar to that for whites, and increased from 1.3/100 000 in 1973 to 2.4/100 000 in 2010, with an annual percent change of 2.0% (95% confidence interval: 1.6-2.4%).
The age-specific incidence rates of AC of the cervix for the 20-44-year age group by median year of birth are shown in Fig. 2 . Among whites (Fig. 2a) , the incidence rates of AC of the cervix showed a generally increasing trend for more recent birth cohorts for age groups between 20 and 44 years. The incidence rate of AC of the cervix among whites aged between 30 and 34 years showed the largest increase, from 0.8 cases/100 000 in the 1940 birth cohort to 3.0 cases/100 000 in the 1975 birth cohort. For both whites (Fig. 2a) and all racial groups 1 9 7 6 1 9 7 9 1 9 8 2 1 9 8 5 1 9 8 8 1 9 9 1 1 9 9 4 1 9 9 7 2 0 0 0 2 0 0 3 2 0 0 6 2 0 0 9 Age-adjusted incidence rate (1/100 000)
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Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited. combined (Fig. 2b) , the birth cohort curves were similarthat is, there was a much sharper increase in the rates after the 1960 birth cohort, but there was a suggestion of a decrease in rates after the 1975 birth cohort. Figure 3a and b presents the results from the APC modeling for whites and all races, respectively, using three different assumptions for the period slope (β p = 0, − 0.01, or 0.01), where the solid line is based on an assumption without an overall period slope and the dotted line and long-dashed line denote the period slope as − 0.01 and 0.01, respectively. These results support the observations from the univariate analyses -that is, the increase in AC of the cervix started among those born around the mid 1940s and accelerated among those born up until around the mid 1960s in both whites and all races, regardless of the assumed period slope. This analysis further suggested that the incidence rates began to slow down after the 1975 birth cohort in both whites and all races combined (Fig. 3a and b) .
Discussion
The results from our current study show that the incidence rates of AC of the cervix have been increasing in both whites and all races combined among young women in the USA. The results also show that the observed increase could be a birth cohort phenomenon. The increase in the incidence of AC of the cervix was first observed in the mid 1940 birth cohort and accelerated around the mid 1960 birth cohort, before slowing down around the 1975 birth cohort.
Although HPV is considered to be a necessary cause for cervical cancer, it is not a sufficient cause for this malignancy (Walboomers et al., 1999) . Thus, the HPV cofactors may play an important role in the development of AC of the cervix (Castellsague et al., 2006) . In-utero exposure to DES has been consistently linked to clear-cell AC of the vagina and cervix in young women, with risks reported to be greater than 20-fold (Herbst et al., 1971; Hatch et al., 1998) , whereas two case reports suggested that DES exposure in utero might also be associated with the development of non-clear-cell AC (Townsend, 1996) . 4 2 .5 1 9 7 2 .5 1 9 8 2 .5 1 9 9 2 .5 2 0 0 2 .5 1 9 3 5 1 9 4 5 1 9 5 5 1 9 6 5 1 9 7 5 1 9 8 5 Age Period Cohort 2 2 .5 3 2 .5 4 2 .5 1 9 7 2 .5 1 9 8 2 .5 1 9 9 2 .5 2 0 0 2 .5 1 9 3 5 1 9 4 5 1 9 5 5 1 9 6 5 1 9 7 5 1 9 8 5
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Age Period Cohort DES is a potent synthetic estrogen that was prescribed to pregnant women between 1940 and 1971 to prevent spontaneous abortion, premature delivery, and related complications of pregnancy in the USA and Europe (IARC, 2012) . The number of women exposed prenatally to DES worldwide is unknown, and most reports on DES use are from the USA (IARC, 2012). It was estimated that 5-10 million US citizens received DES during pregnancy or were exposed to the drug in utero from the 1940s to the 1970s (Giusti et al., 1995) , and most of the exposed women from the US were born between 1948 and 1965 (IARC, 2012 . Interestingly, the time period of DES use among pregnant women in the USA paralleled the observed time interval (i.e. birth cohorts starting from the mid 1940s through to the mid 1975s), with increasing AC of the cervix patterns in our study. These observations seemingly suggest that in-utero exposure to DES might at least partly be responsible for the observed incidence pattern of AC of the cervix, although we note that there were only 66 cases of clear-cell AC (∼2.8%) in the study, and this particular subtype has been reported to have the strongest association with DES exposure in epidemiologic studies. It has been suggested that genomic instability may be an important mechanism for DES-induced carcinogenesis (Boyd et al., 1996) , and animal experiments have suggested that DES disrupts TRP63 expression in mice and induces adenosis lesions in the cervix and vagina (Laronda et al., 2012) .
With respect to other potential risk factors that may help explain the trends observed in our study, previous studies have also linked long-term OC use with an increased risk for AC of the cervix (Madeleine et al., 2001; Smith et al., 2003; Appleby et al., 2007) . A pooled study of eight case-control studies on cervical cancer has also indicated that OC use is a cofactor for AC of the cervix (Castellsague et al., 2006) . OC pills were first approved for use in 1960 in the USA, and this is the most widely used contraceptive method by white women, particularly women in their teens and 20s (Mosher and Jones, 2010; Jones et al., 2012) . The prevalence of OC pill use among women aged between 15 and 44 years in 1982 , 1995 -2008 was 15.6, 17.3, 18.9, and 17.3%, respectively (Mosher and Jones, 2010 . Although OC use might be related to the risk for AC of the cervix, it could not explain why SCC decreased (data not shown) during the time period of the study and why the observed birth cohort pattern of AC of the cervix increased, as OC pills have been associated with all histological types of cervical cancer .
Obesity and body-fat distribution were recently found to be associated with AC of the cervix (Lacey et al., 2003) . The prevalence of adult obesity was reported to have increased between 1980 and 1999 (Flegal et al., 1998 (Flegal et al., , 2002 , and it has levelled off since 2000 in the USA among adult women (Flegal et al., 2012) . This incidence pattern of AC of the cervix does not coincide with the time trend of obesity in the US population as, overall, the incidence of AC of the cervix showed a continuous increase, with an annual percent change of 2.0% after the year 2000. However, obesity, together with other risk factors for cervical cancer, such as long-term OC use, HPV infection, and tobacco smoking, as reviewed previously, could well be the reason for the observed rise in cervical AC incidence in countries without a history of DES use. A period effect (such as screening) also does not seem to be the major reason for the observed incidence pattern of AC of the cervix in this study, as the increasing incidence rate of AC of the cervix started in the 1970s, whereas the endocervical brush was added to cytologic screening in the early 1990s and the US Food and Drug Administration (FDA) approved the first HPV test at the end of the 1990s. In addition, the time interval may be insufficient for a benefit from the HPV vaccine for the observed decrease in rates for recent birth cohorts as the FDA approved Gardasil, the first preventive HPV vaccine, in 2006 (NCI, 2011 .
Given the lower incidence rate and smaller number of cases of AC of the cervix in other racial groups in this study, we did not attempt to analyze the birth cohort pattern for other racial groups as we did for whites. However, the observed birth cohort pattern in analyses that included all racial groups combined was quite similar to that for whites. A second limitation is that, as this is an ecological study, we did not have information on the joint distribution between DES use, other risk factors, and risk for AC of the cervix.
Conclusion
Our analysis of the incidence of AC of the cervix from 1973 to 2010 using data from SEER suggests that exposure to DES in utero might be partly responsible for the observed increase in AC of the cervix in the US population. Targeted screening could be beneficial for women born between the 1940s and the 1970s who were affected by DES exposure in utero, and a yearly examination has been recommended for DES daughters, even after a hysterectomy or menopause (NCI, 2014) .
